NCT06337318 2026-04-21Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaNational Cancer Institute (NCI)Phase 3 Recruiting600 enrolled
NCT01886872 2026-04-13Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting547 enrolled 19 charts